Tekla Capital Management Has Cut By $1.10 Million Its Spark Therapeutics (ONCE) Holding; Laurion Capital Management LP Has Trimmed By $14.63 Million Its Vmware (VMW) Position

June 10, 2018 - By Ellis Scott

Spark Therapeutics, Inc. (NASDAQ:ONCE) Logo

Laurion Capital Management Lp decreased Vmware Inc (VMW) stake by 96.72% reported in 2018Q1 SEC filing. Laurion Capital Management Lp sold 120,900 shares as Vmware Inc (VMW)’s stock rose 6.05%. The Laurion Capital Management Lp holds 4,100 shares with $497,000 value, down from 125,000 last quarter. Vmware Inc now has $60.82B valuation. The stock decreased 0.42% or $0.63 during the last trading session, reaching $149.64. About 1.88 million shares traded. VMware, Inc. (NYSE:VMW) has risen 41.00% since June 10, 2017 and is uptrending. It has outperformed by 28.43% the S&P500. Some Historical VMW News: ; 17/04/2018 – VMware Elevates the Hybrid Cloud Experience with New Releases of vSphere and vSAN; 23/05/2018 – VMWARE INC – CO, OKTA ANNOUNCED A PARTNERSHIP AND INTEGRATION BETWEEN VMWARE WORKSPACE ONE AND OKTA IDENTITY CLOUD; 23/05/2018 – Epoch Concepts Achieves Premier Partner Status, Named by VMware; 17/05/2018 – DELL TECHNOLOGIES INC – DELL IS ALSO CONSIDERING MAINTAINING THE STATUS QUO – SEC FILING; 18/05/2018 – DELL HAS STARTED TALKING TO HOLDERS OF ITS VMWARE TRACKING STOCK TO GAUGE INTEREST IN A MERGER WITH VMWARE – CNBC, CITING; 14/03/2018 – Fornetix Key Orchestration Achieves VMware Ready™ Status; 18/05/2018 – A deal with VMware could theoretically be done in stages, with step one eliminating the tracker and step two merging Dell and VMware; 31/05/2018 – VMware Socialcast Customers Receive Lifeline from lgloo Software Following Their End-of-Life Notification; 01/05/2018 – VMware Advances Networking for the Digital Era with the Virtual Cloud Network; 25/04/2018 – Unitrends Launches Aggressively Priced VM Backup Solution Dedicated to VMware Administrators

Tekla Capital Management Llc decreased Spark Therapeutics Inc. (ONCE) stake by 43.04% reported in 2018Q1 SEC filing. Tekla Capital Management Llc sold 16,660 shares as Spark Therapeutics Inc. (ONCE)’s stock rose 31.00%. The Tekla Capital Management Llc holds 22,046 shares with $1.47 million value, down from 38,706 last quarter. Spark Therapeutics Inc. now has $2.93B valuation. The stock increased 0.55% or $0.43 during the last trading session, reaching $78.27. About 252,701 shares traded. Spark Therapeutics, Inc. (NASDAQ:ONCE) has risen 41.78% since June 10, 2017 and is uptrending. It has outperformed by 29.21% the S&P500. Some Historical ONCE News: ; 30/04/2018 – ONCE TO SELL RARE PEDIATRIC DISEASE PRV FOR $110M; 08/05/2018 – SPARK THERAPEUTICS INC – $587.5 MLN IN CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES AS OF MARCH 31, 2018; 11/05/2018 – Spark Therapeutics Forms Golden Cross: Technicals; 15/05/2018 – Partner Management Buys New 1.7% Position in Spark Therapeutics; 09/03/2018 – CHILDREN’S HOSPITAL OF PHILADELPHIA FOUNDATION – TO CONSIDER VIEW OF ISS, AMONG OTHERS REGARDING ELECTION OF SPARK THERAPEUTICS’ BOARD AT 2018 MEETING; 09/05/2018 – SPARK THERAPEUTICS INC ONCE.O : BMO RAISES TO $78 FROM $64; 08/05/2018 – Spark Therapeutics 1Q Loss $46.4M; 30/04/2018 – SPARK THERAPEUTICS SELLS PRIORITY REVIEW VOUCHER FOR $110M; 09/03/2018 – THE CHILDREN’S HOSPITAL OF PHILADELPHIA FOUNDATION REPORTS 10.7 PCT STAKE IN SPARK THERAPEUTICS AS OF MARCH 9, 2018 – SEC FILING; 08/05/2018 – SPARK THERAPEUTICS 1Q LOSS/SHR $1.25, EST. LOSS/SHR 32C

Laurion Capital Management Lp increased Williams Cos Inc Del (Put) (NYSE:WMB) stake by 118,400 shares to 118,900 valued at $2.96 million in 2018Q1. It also upped Advent Claymore Cv Secs & In (AVK) stake by 117,400 shares and now owns 215,887 shares. Gallagher Arthur J & Co (NYSE:AJG) was raised too.

Analysts await VMware, Inc. (NYSE:VMW) to report earnings on August, 23. They expect $0.97 earnings per share, up 10.23% or $0.09 from last year’s $0.88 per share. VMW’s profit will be $394.26 million for 38.57 P/E if the $0.97 EPS becomes a reality. After $0.87 actual earnings per share reported by VMware, Inc. for the previous quarter, Wall Street now forecasts 11.49% EPS growth.

Since December 12, 2017, it had 0 buys, and 3 sales for $5.91 million activity. Raghuram Rangarajan (Raghu) had sold 23,381 shares worth $2.82 million. The insider POONEN SANJAY sold 10,000 shares worth $1.30M. 2,581 shares were sold by Carli Maurizio, worth $335,220 on Wednesday, January 3. Another trade for 30,000 shares valued at $4.28M was made by RAMASWAMI RAJIV on Friday, June 1.

Investors sentiment decreased to 0.74 in Q1 2018. Its down 0.13, from 0.87 in 2017Q4. It worsened, as 68 investors sold VMW shares while 154 reduced holdings. 62 funds opened positions while 103 raised stakes. 79.49 million shares or 10.15% less from 88.47 million shares in 2017Q4 were reported. Janney Montgomery Scott Limited Liability owns 0.01% invested in VMware, Inc. (NYSE:VMW) for 10,667 shares. Td Asset Mgmt Incorporated holds 16,474 shares or 0% of its portfolio. Moreover, Teacher Retirement System Of Texas has 0.08% invested in VMware, Inc. (NYSE:VMW). Massmutual Co Fsb Adv owns 0% invested in VMware, Inc. (NYSE:VMW) for 12,999 shares. 2,096 are owned by Virtu Lc. Bowen Hanes And Co owns 211,000 shares. Moreover, Clearbridge Invs has 0.3% invested in VMware, Inc. (NYSE:VMW). The New York-based Allsquare Wealth Mgmt Limited has invested 0.02% in VMware, Inc. (NYSE:VMW). Bb&T reported 0.01% in VMware, Inc. (NYSE:VMW). Goelzer Investment reported 0.24% in VMware, Inc. (NYSE:VMW). Strs Ohio owns 83,547 shares. Bender Robert And Associates holds 2.96% or 43,958 shares. Clinton Grp Incorporated owns 58,923 shares or 0.77% of their US portfolio. Mitsubishi Ufj Tru holds 0.03% of its portfolio in VMware, Inc. (NYSE:VMW) for 161,653 shares. Nordea Mgmt holds 78,336 shares.

More notable recent VMware, Inc. (NYSE:VMW) news were published by: Seekingalpha.com which released: “VMware, Inc. (VMW) CEO Pat Gelsinger on Q1 2019 Results – Earnings Call Transcript” on June 01, 2018, also Fool.com with their article: “Another Strong Quarter for VMware Amid Dell Deal Uncertainty” published on June 04, 2018, Seekingalpha.com published: “VMware, Inc. 2019 Q1 – Results – Earnings Call Slides” on June 01, 2018. More interesting news about VMware, Inc. (NYSE:VMW) were released by: Seekingalpha.com and their article: “Dell Going Public Just Got More Interesting” published on May 22, 2018 as well as Seekingalpha.com‘s news article titled: “VMware Looks Unstoppable As Growth In Core Markets Accelerates” with publication date: June 04, 2018.

Among 50 analysts covering VMware Inc (NYSE:VMW), 21 have Buy rating, 1 Sell and 28 Hold. Therefore 42% are positive. VMware Inc had 185 analyst reports since July 22, 2015 according to SRatingsIntel. The rating was maintained by Jefferies on Friday, August 11 with “Buy”. BMO Capital Markets maintained VMware, Inc. (NYSE:VMW) rating on Wednesday, January 27. BMO Capital Markets has “Market Perform” rating and $52 target. The firm has “Outperform” rating given on Tuesday, September 1 by Oppenheimer. The firm earned “Buy” rating on Monday, May 21 by Credit Suisse. The stock has “Hold” rating by BMO Capital Markets on Tuesday, September 1. The firm has “Hold” rating given on Tuesday, January 24 by Maxim Group. The company was maintained on Thursday, March 1 by Jefferies. The stock has “Hold” rating by Cowen & Co on Tuesday, November 14. William Blair maintained VMware, Inc. (NYSE:VMW) on Sunday, September 6 with “Market Perform” rating. The stock of VMware, Inc. (NYSE:VMW) has “Market Perform” rating given on Tuesday, October 13 by JMP Securities.

More important recent Spark Therapeutics, Inc. (NASDAQ:ONCE) news were published by: Seekingalpha.com which released: “Weekly Wrap For June 8, 2018” on June 10, 2018, also Seekingalpha.com published article titled: “US IPO Weekly Recap: June Kicks Off To A Slow Start With 2 IPO Pricings But Only One Trading”, Seekingalpha.com published: “Wave Life Sciences: What’s Cooking Behind This Innovator?” on May 23, 2018. More interesting news about Spark Therapeutics, Inc. (NASDAQ:ONCE) was released by: Fool.com and their article: “3 Top Biotech Stocks to Buy in June” with publication date: June 04, 2018.

Among 26 analysts covering Spark Therapeutics (NASDAQ:ONCE), 15 have Buy rating, 2 Sell and 9 Hold. Therefore 58% are positive. Spark Therapeutics had 79 analyst reports since August 21, 2015 according to SRatingsIntel. Wedbush maintained it with “Sell” rating and $40.0 target in Thursday, January 25 report. Credit Suisse maintained the shares of ONCE in report on Thursday, March 8 with “Outperform” rating. The firm earned “Outperform” rating on Wednesday, May 9 by BMO Capital Markets. The company was downgraded on Tuesday, December 12 by Leerink Swann. SunTrust maintained Spark Therapeutics, Inc. (NASDAQ:ONCE) on Friday, October 13 with “Buy” rating. BMO Capital Markets maintained Spark Therapeutics, Inc. (NASDAQ:ONCE) rating on Wednesday, February 21. BMO Capital Markets has “Outperform” rating and $64 target. The firm has “Buy” rating given on Friday, June 3 by Cantor Fitzgerald. The firm has “Buy” rating by Cantor Fitzgerald given on Monday, December 11. As per Friday, September 2, the company rating was initiated by Stifel Nicolaus. The rating was maintained by Leerink Swann with “Hold” on Monday, May 7.

Tekla Capital Management Llc increased Danaher Corporation (NYSE:DHR) stake by 59,644 shares to 74,847 valued at $7.33M in 2018Q1. It also upped Allergan Plc stake by 40,656 shares and now owns 248,836 shares. Sarepta Therapeutics Inc. (NASDAQ:SRPT) was raised too.

Analysts await Spark Therapeutics, Inc. (NASDAQ:ONCE) to report earnings on August, 1. They expect $-0.39 earnings per share, up 79.37% or $1.50 from last year’s $-1.89 per share. After $-1.25 actual earnings per share reported by Spark Therapeutics, Inc. for the previous quarter, Wall Street now forecasts -68.80% EPS growth.

Investors sentiment decreased to 1.19 in Q1 2018. Its down 0.24, from 1.43 in 2017Q4. It turned negative, as 21 investors sold ONCE shares while 42 reduced holdings. 33 funds opened positions while 42 raised stakes. 36.74 million shares or 2.75% more from 35.76 million shares in 2017Q4 were reported. Principal Financial Group Inc Inc holds 0% in Spark Therapeutics, Inc. (NASDAQ:ONCE) or 61,967 shares. Fred Alger Management has 19,000 shares for 0.01% of their portfolio. State Street has invested 0.01% in Spark Therapeutics, Inc. (NASDAQ:ONCE). Amg Natl Tru Natl Bank stated it has 5,000 shares or 0.02% of all its holdings. Metropolitan Life New York accumulated 9,027 shares. Federated Investors Pa holds 0.29% or 1.50M shares. Macquarie Gp has invested 0.05% of its portfolio in Spark Therapeutics, Inc. (NASDAQ:ONCE). Susquehanna Int Group Inc Llp invested in 0% or 29,421 shares. Ameriprise Finance Incorporated reported 168,028 shares stake. Rhenman And Prtn Asset Mngmt Ab stated it has 0.55% in Spark Therapeutics, Inc. (NASDAQ:ONCE). Zurcher Kantonalbank (Zurich Cantonalbank) holds 0% or 2,975 shares. Sumitomo Mitsui Asset Management has 0.02% invested in Spark Therapeutics, Inc. (NASDAQ:ONCE) for 22,958 shares. Northern Trust holds 0.01% or 339,096 shares. Ipswich Investment Management has 9,264 shares. 60 were reported by Winslow Evans And Crocker.

VMware, Inc. (NYSE:VMW) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>